logo
Plus   Neg
Share
Email

Bayer : UK Oks Xarelto To Treat Children With Venous Thromboembolism And To Prevent VTE Recurrence

Bayer (BAYZF.PK,BAYRY.PK,BYR.L) said Monday that the U.K. has approved the use of its oral Factor Xa inhibitor Xarelto or rivaroxaban to treat venous thromboembolism or VTE and to prevent VTE recurrence in children from birth to below 18 years after at least 5 days of initial parenteral anticoagulation treatment.

Paediatric VTE includes cerebral vein and sinus thrombosis (a blood clot in the brain), central venous catheter related thrombosis, pulmonary embolism (a blood clot that travels to the lung), and deep vein thrombosis (a blood clot in a deep vein).

The U.K. has also approved the use of a new formulation and strength granules for oral suspension 1mg/ml.

The approval follows a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency in November 2020, which recommended approval in the European Union. The CHMP recommendation and approval also apply to the UK.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Credit Suisse Group AG were losing around 6 percent in Swiss trading after the banking major slipped to a loss in its first quarter from a profit last year on hefty charge related to a US-based hedge fund. Net revenues, however, were significantly higher. Looking ahead, the company expects market volumes to return to lower, and more normal, levels in the coming quarters. Metal Ware Corp. is recalling about 5,350 units of NESCO coffee bean roasters citing fire risk, the U.S. Consumer Product Safety Commission said in a statement. The recall involves Model CR-04-13 Coffee Bean Roasters with a date code of 2520 or 3220 printed at the bottom right of the ETL Intertek label on the product and on the box. Pfizer has uncovered the counterfeit versions of its Covid-19 vaccine in Mexico and Poland, according to a Wall Street Journal report. The vaccine was developed in partnership with Germany's BioNTech SE. Though there have been several reports of counterfeit versions of the Covid-19 vaccine, this seems to be the first confirmed instance.
Follow RTT